N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.63p
   
  • Change Today:
      0.025p
  • 52 Week High: 0.65p
  • 52 Week Low: 0.55p
  • Currency: UK Pounds
  • Shares Issued: 832.28m
  • Volume: 3,077,257
  • Market Cap: £5.20m

Regulatory News

Interim Results 25-Sep-2025 07:00 RNS
Partnership with University of Strathclyde’... 23-Sep-2025 07:00 RNS
N4 Pharma’s Nuvec® Targets Lung Cance... 22-Sep-2025 07:00 RNS
Notice of Results, Analyst & Investor Presentation 19-Sep-2025 07:00 RNS
Directorate Change 08-Jul-2025 07:00 RNS
Result of AGM 30-Jun-2025 14:15 RNS
AGM Statement 30-Jun-2025 07:00 RNS
Final Results, Annual Report and Notice of AGM 06-Jun-2025 07:00 RNS
TR-1: Notification of major holdings 23-May-2025 12:37 RNS
Holding(s) in Company 21-May-2025 16:11 RNS
Change of Registered Address 15-May-2025 15:13 RNS
N4 101 In Vivo Study Results 12-May-2025 07:00 RNS
Holding(s) in Company 09-May-2025 08:24 RNS
Holding(s) in Company 29-Apr-2025 16:25 RNS
Holding(s) in Company 29-Apr-2025 11:05 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.63p
Change Today 0.025p
% Change 4.17 %
52 Week High 0.65p
52 Week Low 0.55p
Volume 3,077,257
Shares Issued 832.28m
Market Cap £5.20m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average
Value
55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average
Income Not Available
Growth
25.67% above the market average25.67% above the market average25.67% above the market average25.67% above the market average25.67% above the market average
17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average

N4 Pharma Dividends

No dividends found

Trades for 06-Nov-2025

Time Volume / Share Price
12:39 1,500,000 @ 0.63p
11:07 6,769 @ 0.65p
10:27 100,000 @ 0.65p
10:00 474,683 @ 0.63p
09:56 923,036 @ 0.65p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page